The Endocannabinoid System Explained: How Medical Cannabis Works

The endocannabinoid system (ECS) is a biological system present in every human body that is directly responsible for the therapeutic effects of medical cannabis. Understanding the ECS helps explain why cannabis works as medicine and how it interacts with fundamental bodily processes including pain perception, mood regulation, appetite, sleep, and immune function.

Two Types of Cannabinoids

Cannabinoids come in two forms. Endogenous cannabinoids (endocannabinoids) are produced naturally inside your body and regulate basic functions by interacting with cannabinoid receptors. The most important endocannabinoids are anandamide (called the "bliss molecule") and 2-AG. Exogenous cannabinoids come from outside the body — specifically from the cannabis plant. THC and CBD are the most studied exogenous cannabinoids. When consumed, they interact with the same receptor system as your body's own endocannabinoids.

CB1 and CB2 Receptors

The endocannabinoid system has two primary receptor types. CB1 receptors are found throughout the body but are especially concentrated in the brain and spinal cord — particularly in areas controlling appetite, emotional processing, memory, and pain perception. CB2 receptors are concentrated in the peripheral nervous system and immune tissues. When CB2 receptors are stimulated, they reduce inflammation — a key mechanism for treating many diseases. THC interacts directly with both CB1 and CB2 receptors, while CBD works indirectly by inhibiting the enzyme FAAH, which breaks down anandamide.

What the ECS Regulates

The endocannabinoid system influences an remarkably broad range of functions: digestion, inflammation, body temperature, memory, movement, cardiovascular function, mood, metabolism, appetite, pain sensation, and immune response. Notably, endocannabinoid levels are elevated in people with conditions including anxiety, chronic pain, arthritis, and Parkinson's disease — suggesting the ECS is actively trying to restore balance. Tumor cells have also been found to contain higher numbers of endocannabinoid receptors than healthy cells, a finding that has implications for cancer research.